company background image
300573 logo

Shenyang Xingqi PharmaceuticalLtd SZSE:300573 Stock Report

Last Price

CN¥69.80

Market Cap

CN¥12.2b

7D

-1.1%

1Y

-30.9%

Updated

31 Jan, 2025

Data

Company Financials

Shenyang Xingqi Pharmaceutical Co.,Ltd.

SZSE:300573 Stock Report

Market Cap: CN¥12.2b

300573 Stock Overview

Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. More details

300573 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Shenyang Xingqi Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shenyang Xingqi PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥69.80
52 Week HighCN¥214.36
52 Week LowCN¥64.88
Beta0.20
1 Month Change0.029%
3 Month Change-16.51%
1 Year Change-30.89%
3 Year Change36.64%
5 Year Change86.77%
Change since IPO1,741.29%

Recent News & Updates

These 4 Measures Indicate That Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Using Debt Safely

Jan 05
These 4 Measures Indicate That Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Using Debt Safely

Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Oct 23
Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Recent updates

These 4 Measures Indicate That Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Using Debt Safely

Jan 05
These 4 Measures Indicate That Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Using Debt Safely

Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Oct 23
Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce

Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

Sep 08
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

Aug 19
With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Jul 24
What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Jun 28
Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

May 21
Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

May 10
After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

May 07
We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Mar 15
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Shareholder Returns

300573CN PharmaceuticalsCN Market
7D-1.1%0.04%0.07%
1Y-30.9%8.3%18.4%

Return vs Industry: 300573 underperformed the CN Pharmaceuticals industry which returned 8.3% over the past year.

Return vs Market: 300573 underperformed the CN Market which returned 18.4% over the past year.

Price Volatility

Is 300573's price volatile compared to industry and market?
300573 volatility
300573 Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.8%
10% most volatile stocks in CN Market10.8%
10% least volatile stocks in CN Market4.0%

Stable Share Price: 300573 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300573's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19771,995E. Gaowww.sinqi.com

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products.

Shenyang Xingqi Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Shenyang Xingqi PharmaceuticalLtd's earnings and revenue compare to its market cap?
300573 fundamental statistics
Market capCN¥12.23b
Earnings (TTM)CN¥348.47m
Revenue (TTM)CN¥1.80b

35.1x

P/E Ratio

6.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300573 income statement (TTM)
RevenueCN¥1.80b
Cost of RevenueCN¥403.79m
Gross ProfitCN¥1.40b
Other ExpensesCN¥1.05b
EarningsCN¥348.47m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 22, 2025

Earnings per share (EPS)1.99
Gross Margin77.59%
Net Profit Margin19.34%
Debt/Equity Ratio14.1%

How did 300573 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

132%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 01:50
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenyang Xingqi Pharmaceutical Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tielin ChenTopsperity Securities
Jing ChenTopsperity Securities